Praziquantel decreases fecundity in Schistosoma mansoni adult worms that survive treatment: evidence from a laboratory life-history trade-offs selection study

BACKGROUND: Mass drug administration of praziquantel is the World Health Organization’s endorsed control strategy for schistosomiasis. A decade of annual treatments across sub-Saharan Africa has resulted in significant reductions of infection prevalence and intensity levels, although ‘hotspots’ rema...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamberton, Poppy H.L., Faust, Christina L., Webster, Joanne P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472905/
https://www.ncbi.nlm.nih.gov/pubmed/28622767
http://dx.doi.org/10.1186/s40249-017-0324-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472905/
https://www.ncbi.nlm.nih.gov/pubmed/28622767
http://dx.doi.org/10.1186/s40249-017-0324-0

Ejemplares similares